A citation-based method for searching scientific literature

Lisa K Dunnwald, Mary Anne Rossing, Christopher I Li. Breast Cancer Res 2007
Times Cited: 444







List of co-cited articles
413 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
10

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
10

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
C Davies, J Godwin, R Gray, M Clarke, D Cutter, S Darby, P McGale, H C Pan, C Taylor, Y C Wang,[...]. Lancet 2011
9


American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, D Craig Allred, Karen L Hagerty, Sunil Badve, Patrick L Fitzgibbons, Glenn Francis, Neil S Goldstein, Malcolm Hayes,[...]. J Clin Oncol 2010
8

Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
Emad A Rakha, Maysa E El-Sayed, Andrew R Green, E Claire Paish, Desmond G Powe, Julia Gee, Robert I Nicholson, Andrew H S Lee, John F R Robertson, Ian O Ellis. J Clin Oncol 2007
200
8

Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Soo Youn Bae, Sangmin Kim, Jun Ho Lee, Hyun-Chul Lee, Se Kyung Lee, Won Ho Kil, Seok Won Kim, Jeong Eon Lee, Seok Jin Nam. BMC Cancer 2015
70
11

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006
8

Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.
Victor R Grann, Andrea B Troxel, Naseem J Zojwalla, Judith S Jacobson, Dawn Hershman, Alfred I Neugut. Cancer 2005
148
7

US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.
Nadia Howlader, Sean F Altekruse, Christopher I Li, Vivien W Chen, Christina A Clarke, Lynn A G Ries, Kathleen A Cronin. J Natl Cancer Inst 2014
584
7

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
7

Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study.
C A Purdie, P Quinlan, L B Jordan, A Ashfield, S Ogston, J A Dewar, A M Thompson. Br J Cancer 2014
94
7



Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update.
Kimberly H Allison, M Elizabeth H Hammond, Mitchell Dowsett, Shannon E McKernin, Lisa A Carey, Patrick L Fitzgibbons, Daniel F Hayes, Sunil R Lakhani, Mariana Chavez-MacGregor, Jane Perlmutter,[...]. J Clin Oncol 2020
149
6

Triple-negative breast cancer: clinical features and patterns of recurrence.
Rebecca Dent, Maureen Trudeau, Kathleen I Pritchard, Wedad M Hanna, Harriet K Kahn, Carol A Sawka, Lavina A Lickley, Ellen Rawlinson, Ping Sun, Steven A Narod. Clin Cancer Res 2007
5

Time to stop progesterone receptor testing in breast cancer management.
Ivo A Olivotto, Pauline T Truong, Caroline H Speers, Vanessa Bernstein, Sharon J Allan, Seamus J Kelly, Mary L Lesperance. J Clin Oncol 2004
61
8

Cancer Statistics, 2017.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2017
5

Luminal B breast cancer: molecular characterization, clinical management, and future perspectives.
Felipe Ades, Dimitrios Zardavas, Ivana Bozovic-Spasojevic, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Giuseppe Viale, Christos Sotiriou, Martine Piccart. J Clin Oncol 2014
162
5

Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer.
Aleix Prat, Maggie Chon U Cheang, Miguel Martín, Joel S Parker, Eva Carrasco, Rosalía Caballero, Scott Tyldesley, Karen Gelmon, Philip S Bernard, Torsten O Nielsen,[...]. J Clin Oncol 2013
332
5

Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Grazia Arpino, Heidi Weiss, Adrian V Lee, Rachel Schiff, Sabino De Placido, C Kent Osborne, Richard M Elledge. J Natl Cancer Inst 2005
357
5

Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy.
Xiaojiang Cui, Rachel Schiff, Grazia Arpino, C Kent Osborne, Adrian V Lee. J Clin Oncol 2005
323
5

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
5

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Christina Davies, Hongchao Pan, Jon Godwin, Richard Gray, Rodrigo Arriagada, Vinod Raina, Mirta Abraham, Victor Hugo Medeiros Alencar, Atef Badran, Xavier Bonfill,[...]. Lancet 2013
5

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.
Hongchao Pan, Richard Gray, Jeremy Braybrooke, Christina Davies, Carolyn Taylor, Paul McGale, Richard Peto, Kathleen I Pritchard, Jonas Bergh, Mitch Dowsett,[...]. N Engl J Med 2017
476
5

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
Brian D Lehmann, Joshua A Bauer, Xi Chen, Melinda E Sanders, A Bapsi Chakravarthy, Yu Shyr, Jennifer A Pietenpol. J Clin Invest 2011
5

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Daniel F Hayes, Charles E Geyer, Elizabeth C Dees, Matthew P Goetz, John A Olson,[...]. N Engl J Med 2018
755
5



The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.
R Salgado, C Denkert, S Demaria, N Sirtaine, F Klauschen, G Pruneri, S Wienert, G Van den Eynden, F L Baehner, F Penault-Llorca,[...]. Ann Oncol 2015
4

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.
Peter Schmid, Sylvia Adams, Hope S Rugo, Andreas Schneeweiss, Carlos H Barrios, Hiroji Iwata, Véronique Diéras, Roberto Hegg, Seock-Ah Im, Gail Shaw Wright,[...]. N Engl J Med 2018
4

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John M S Bartlett, Michael Bilous, Patrick Fitzgibbons,[...]. J Clin Oncol 2013
4

Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers.
Mehrdad Nadji, Carmen Gomez-Fernandez, Parvin Ganjei-Azar, Azorides R Morales. Am J Clin Pathol 2005
284
4

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
4

The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine.
Jeffrey S Ross, Elzbieta A Slodkowska, W Fraser Symmans, Lajos Pusztai, Peter M Ravdin, Gabriel N Hortobagyi. Oncologist 2009
728
4


Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer.
Armando E Giuliano, Stephen B Edge, Gabriel N Hortobagyi. Ann Surg Oncol 2018
127
4

Combinatorial biomarker expression in breast cancer.
Emad A Rakha, Jorge S Reis-Filho, Ian O Ellis. Breast Cancer Res Treat 2010
133
4

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, Steven Shak, Chungyeul Kim, Joffre Baker, Wanseop Kim, Maureen Cronin, Frederick L Baehner, Drew Watson, John Bryant,[...]. J Clin Oncol 2006
4

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.
Giuseppe Viale, Meredith M Regan, Eugenio Maiorano, Mauro G Mastropasqua, Patrizia Dell'Orto, Birgitte Bruun Rasmussen, Johnny Raffoul, Patrick Neven, Zsolt Orosz, Stephen Braye,[...]. J Clin Oncol 2007
302
4


Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?
Leen De Maeyer, Erik Van Limbergen, Katelijne De Nys, Philippe Moerman, Nathalie Pochet, Wouter Hendrickx, Hans Wildiers, Robert Paridaens, Ann Smeets, Marie-Rose Christiaens,[...]. J Clin Oncol 2008
69
5

Lack of either estrogen or progesterone receptor expression is associated with poor survival outcome among luminal A breast cancer subtype.
Seho Park, Byeong-Woo Park, Tae Hyun Kim, Chang Wan Jeon, Han-Sung Kang, Jung-Eun Choi, Ki-Tae Hwang, In Cheol Kim. Ann Surg Oncol 2013
25
16

Characterization of estrogen receptor-negative/progesterone receptor-positive breast cancer.
Tiansheng Shen, Margaret Brandwein-Gensler, Omar Hameed, Gene P Siegal, Shi Wei. Hum Pathol 2015
25
16

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
G Curigliano, H J Burstein, E P Winer, M Gnant, P Dubsky, S Loibl, M Colleoni, M M Regan, M Piccart-Gebhart, H-J Senn,[...]. Ann Oncol 2017
473
4

Heterogeneity in breast cancer.
Kornelia Polyak. J Clin Invest 2011
489
4

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park,[...]. N Engl J Med 2004
4

Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
Yunhai Li, Dejuan Yang, Xuedong Yin, Xiang Zhang, Jiefeng Huang, Yusheng Wu, Mengxue Wang, Zhiying Yi, Hongyuan Li, Hongzhong Li,[...]. JAMA Netw Open 2020
24
16

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial.
Jack Cuzick, Ivana Sestak, Simon Cawthorn, Hisham Hamed, Kaija Holli, Anthony Howell, John F Forbes. Lancet Oncol 2015
226
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.